1. Home
  2. OMER vs AMWD Comparison

OMER vs AMWD Comparison

Compare OMER & AMWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omeros Corporation

OMER

Omeros Corporation

HOLD

Current Price

$10.80

Market Cap

788.4M

Sector

Health Care

ML Signal

HOLD

Logo American Woodmark Corporation

AMWD

American Woodmark Corporation

HOLD

Current Price

$39.48

Market Cap

872.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMER
AMWD
Founded
1994
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Forest Products
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
788.4M
872.8M
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
OMER
AMWD
Price
$10.80
$39.48
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$32.50
$63.50
AVG Volume (30 Days)
703.2K
227.3K
Earning Date
03-12-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,868,000.00
$1,709,585,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.95
$35.51
52 Week High
$17.65
$72.16

Technical Indicators

Market Signals
Indicator
OMER
AMWD
Relative Strength Index (RSI) 39.68 31.76
Support Level $10.55 N/A
Resistance Level $11.93 $58.01
Average True Range (ATR) 0.46 1.72
MACD -0.06 -0.07
Stochastic Oscillator 9.85 31.79

Price Performance

Historical Comparison
OMER
AMWD

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

About AMWD American Woodmark Corporation

American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.

Share on Social Networks: